Ethnic background as a risk factor for advanced age-related macular degeneration in Israel.
BACKGROUND
Age-related macular degeneration is the most common cause of legal blindness in the developed world including Israel. Ethnic background is a risk factor for advanced AMD in several populations, however the relative prevalence of this disease in different ethnic groups in the Middle East is unknown.


OBJECTIVE
To compare the prevalence of advanced AMD in Arabs and Jews in Israel.


METHODS
We performed a retrospective analysis of two independent groups of patients: the first group comprised a sequential series of Jerusalem residents who underwent photodynamic therapy for neovascular AMD (PDT group), and the second group consisted of all individuals in Jerusalem who received a blind certificate due to AMD (legal blindness group). Control groups were assessed to exclude inherited ethnic associated bias in the two study groups.


RESULTS
The PDT group included 146 patients: 142 were Jews (97.3%) and 4 were Arabs (2.7%). The legal blindness group included 340 Jerusalem residents: 326 Jews (96%) and 14 Arabs (4%). The number of Arab AMD patients in the two groups was lower than expected based on the ethnic composition of the age-matched Jerusalem population (P = 0.0002 for the PDT group, and P < 0.0001 for the legal blindness group). By contrast, the number of non-AMD Arab patients who were treated in the same clinic and the number of Arabs who received a blind certificate for diabetic retinopathy was not different from expected based on their relative number in the Jerusalem population.


CONCLUSIONS
Advanced AMD is less common in the Arab than the Jewish population of Jerusalem. Genetic and environmental factors may account for this difference. A population-based study is required to assess the overall prevalence of AMD in Jews and Arabs.
Asleh
Saleh Abu
SA
Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Chowers
Itay
I
D000368:Aged; D018912:Arabs / Q000706:statistics & numerical data*; D001766:Blindness / Q000453:epidemiology; D003930:Diabetic Retinopathy / Q000453:epidemiology; D006801:Humans; D007557:Israel / Q000453:epidemiology; D007585:Jews / Q000706:statistics & numerical data*; D008268:Macular Degeneration / Q000208:ethnology* / Q000628:therapy; D010778:Photochemotherapy; D012189:Retrospective Studies; D012307:Risk Factors